Skip to content

STATE Trial: SusTained Attention Training to Enhance Sleep

STATE Trial: SusTained Attention Training to Enhance Sleep

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02921074
Acronym
STATE
Enrollment
23
Registered
2016-09-30
Start date
2016-03-31
Completion date
2018-04-10
Last updated
2018-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Brief summary

This study is a validation study to document the acceptability of the Tonic and Phasic Alertness Training (TAPAT) training program in older adults with chronic late-life insomnia. The goal of this study is to employ a computerized attention-training program, TAPAT, designed for chronic late-life insomnia in a randomized, controlled trial to assess feasibility and initial efficacy in this population.

Interventions

Sponsors

University of California, San Francisco
CollaboratorOTHER
Posit Science Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Participant must be between ages 55 and 80. * Participant must meet current diagnostic criteria for Primary Insomnia Disorder based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). * Participant with hypertension must be undergoing treatment for this condition and on a stable medication regimen for hypertension for ≥ 8 weeks prior to screening. * Participant must be a fluent English speaker * Participant must have adequate visual, auditory, and motor capacity to use computerized intervention * Participant must be willing to wear Microsoft Band 2 watch to track sleep patterns

Exclusion criteria

* Participants with cognitive impairment, delirium or dementia, or evidence of cognitive impairment from a pre-existing cause. * Participants with untreated psychiatric conditions, including substance abuse/dependence disorders, untreated obstructive sleep apnea, diagnosis of other sleep disorders (e.g., restless legs syndrome), recent hospitalization, ongoing chemotherapy or other cancer treatment, and concurrent engagement in another insomnia treatment. * Participants enrolled in another concurrent research study. * Participants who have difficulty performing assessments or comprehending or following spoken instructions, in the judgment of the screening clinician. * Participants using computer-based cognitive training programs or has used them within a month of the consent date.

Design outcomes

Primary

MeasureTime frame
Sleep efficiency and sleep duration scores on the Pittsburg Sleep Quality Index4 months
Sleep duration obtained by actigraphy (Microsoft Band 2 watch)4 months
Sleep duration obtained by sleep diary4 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026